The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.
Open accessAbstract
It is recognized that high-level resistance to 3'-azido-3'-deoxythymidine (AZT, zidovudine, or Retrovir) is conferred by the presence of four mutations in the human immunodeficiency virus (HIV) reverse transcriptase [RT; deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (RNA-directed), EC 2.7.7.49] coding sequence. However, a number of clinical isolates have been observed that exhibit high-level resistance but contain only three of the four identified mutations (Asn-67, Arg-70, and Tyr-215). Construction of a molecular clone with this genotype gave rise to only a partially resistant virus, raising the possibility that an additional mutation existed in some clinical isolates. Using an HIV marker rescue system, we have mapped and identified a fifth mutation conferring resistance to zidovudine, namely, methionine to leucine at codon 41 of HIV RT. An infectious molecular clone containing this mutation together with three previously identified mutations in the RT coding sequence yielded highly resistant HIV after transfection of T cells. Direct detection of the fifth mutation in DNA samples from cocultured peripheral blood lymphocytes by the PCR revealed that it occurred relatively early in the development of zidovudine resistance. However, this mutation was only detected after the appearance of the codon 215 change in the RT coding sequence. Identification of this mutation in addition to the other known mutations conferring resistance enables rapid and direct correlation between an RT genotype and sensitivity of the virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559
Self-citationMultiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Self-citationZOLLER, M. J., & SMITH, M. (1984) · DNA · doi:10.1089/dna.1.1984.3.479 · Cited by 886
Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
St. Clair, M. H., Martin, J. L., Tudor-Williams, G., Bach, M. C., Vavro, C. L., King, D. M., Kellam, P., Kemp, S. D., & Larder, B. A. (1991) · Science · doi:10.1126/science.1716788 · Cited by 679
Self-citationBoucher, C. A. B., O'Sullivan, E., Mulder, J. W., Ramautarsing, C., Kellam, P., Darby, G., Lange, J. M. A., Goudsmit, J., & Larder, B. A. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.1.105 · Cited by 352
Self-citationSalahuddin, S. Z., Markhamt, P. D., Wong-staal, F., Franchini, G., Kalyanaraman, V. S., & Gallo, R. C. (1983) · Virology · doi:10.1016/0042-6822(83)90395-1 · Cited by 324
Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
Chesebro, B., & Wehrly, K. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3779-3788.1988 · Cited by 304
Richman, D. D., Grimes, J. M., & Lagakos, S. W. (1990) · PubMed · Cited by 247
Larder, B. A., Kemp, S. D., & Purifoy, D. J. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4803 · Cited by 179
Self-citationBoucher, C. A. B., Lange, J. M. A., Goudsmit, J., Mulder, J. W., Tersmette, M., de Goede, R. E. Y., Kellam, P., Darby, G., & Larder, B. A. (1990) · The Lancet · doi:10.1016/0140-6736(90)93391-2 · Cited by 179
Self-citationAIDS virus reverse transcriptase defined by high level expression in Escherichia coli.
Larder, B. A., Purifoy, D. J. M., Powell, K. L., & Darby, G. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02623.x · Cited by 124
Self-citationDecreased In Vitro Susceptibility to Zidovudine of HIV Isolates Obtained from Patients with AIDS
Land, S., Treloar, G., McPhee, D. A., Birch, C. J., Doherty, R. R., Cooper, D. A., & Gust, I. D. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.2.326 · Cited by 104
Japour, A. J., Chatis, P. A., Eigenrauch, H. A., & Crumpacker, C. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3092 · Cited by 74
Cited by
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy
Larder, B. A., Kemp, S. D., & Harrigan, P. R. (1995) · Science · doi:10.1126/science.7542804 · Cited by 623
Self-citationTisdale, M., Kemp, S. D., Parry, N. R., & Larder, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5653 · Cited by 603
Self-citationNevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
Richman, D. D., Havlir, D., Corbeil, J., Looney, D., Ignacio, C., Spector, S. A., Sullivan, J., Cheeseman, S., Barringer, K., & Pauletti, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1660-1666.1994 · Cited by 576
Metadata
- Authors
- Kellam, P., Boucher, C. A., & Larder, B. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-03
- Volume
- 89
- Issue
- 5
- Pages
- 1934-1938
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2074495023
- Cited by
- 413
- References
- 14
- FWCI
- 43.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.